In this study, I examined whether sperm hyperactivation in hamster is regulated by steroid hormones such as estrogen (estradiol, E 2 ) and progesterone. Although sperm hyperactivation was enhanced by progesterone, 17b-estradiol (17bE 2 ) itself did not affect sperm hyperactivation. However, 17bE 2 suppressed progesterone-enhanced hyperactivation in a concentration-dependent manner through non-genomic pathways when spermatozoa were exposed to 17bE 2 at the same time or before exposure to progesterone. When spermatozoa were exposed to 17bE 2 after exposure to progesterone, 17bE 2 did not suppress progesterone-enhanced hyperactivation. Moreover, 17a-estradiol, an inactive isomer of E 2 , did not suppress progesterone-enhanced hyperactivation. Observations using a FITC-conjugated 17bE 2 showed that it binds to the acrosome region of the sperm head. Binding of 17bE 2 to spermatozoa was not inhibited by progesterone, although 17bE 2 did not suppress progesterone-enhanced hyperactivation when spermatozoa were exposed to 17bE 2 after exposure to progesterone. On the other hand, binding of progesterone to spermatozoa was also not inhibited by 17bE 2 even if progesterone-enhanced hyperactivation was suppressed by 17bE 2 . Although tyrosine phosphorylations of sperm proteins were enhanced by progesterone, enhancement of tyrosine phosphorylations by progesterone was suppressed by 17bE 2 . Moreover, tyrosine phosphorylations were inhibited by 17bE 2 when only 17bE 2 was added to the medium. From these results, it is likely that 17bE 2 competitively suppresses progesterone-enhanced hyperactivation through the inhibition of tyrosine phosphorylations via non-genomic pathways.
Introduction
After capacitation, mammalian spermatozoa fertilize eggs. Capacitated spermatozoa exhibit the acrosome reaction (AR) and hyperactivation. The AR is a modified exocytotic event involving the acrosome and the overlying sperm plasma membrane (Yudin et al. 1988 , Yanagimachi 1994 ). The AR is required for penetration of the zona pellucida (ZP) of the egg and for sperm-egg plasma membrane fusion. Hyperactivation is a specialized movement of the sperm flagellum creating a propulsive force for passing through the ZP. Hyperactivated spermatozoa exhibit a large bend amplitude, whiplash and frenzied flagellar movements (Yanagimachi 1994 , Fujinoki et al. 2001a , Suarez & Ho 2003 .
Albumin, calcium and bicarbonate are important molecules in the capacitation process. Albumin promotes capacitation by removing cholesterol from the sperm plasma membrane (Langlais & Roberts 1985) . Calcium and bicarbonate are involved in several intracellular signals such as the stimulation of adenylate cyclase, production of cAMP, and protein phosphorylation (Okamura et al. 1985 , Ho & Suarez 2001 , Ho et al. 2002 . For protein phosphorylations, it has been suggested that tyrosine phosphorylations are closely associated with capacitation (Visconti et al. 1995 , Fujinoki et al. 2001b , 2006 , Jha & Shivaji 2001 . Moreover, 80 and/or 85 kDa tyrosine phosphorylations are regulated by calcium/ calmodulin-dependent signals (Carrera et al. 1996) and protein phosphatase 1 (Suzuki et al. 2010) , and are identified as A-kinase anchoring protein (AKAP; Carrera et al. 1996 , Jha & Shivaji 2002 .
Progesterone isolated from follicular fluid is a stimulator of human sperm AR (Osman et al. 1989) . Progesterone stimulates the AR via non-genomic regulation (Baldi et al. 1998 , 2009 , Lö sel & Wehling 2003 , Luconi et al. 2004 . In human spermatozoa, progesterone stimulates calcium influx, tyrosine phosphorylation, chloride efflux, and cAMP increase (Lösel & Wehling 2003 , Harper et al. 2004 , Luconi et al. 2004 , Baldi et al. 2009 ). It also stimulates ZP penetration and the AR in hamster spermatozoa (Libersky & Boatman 1995b , Llanos & Anabalon 1996 . Although spermatozoa do not have a classic intracellular progesterone receptor (PGR), a PGR is present in the cell membrane (Sabeur et al. 1996 , Baldi et al. 1998 , 2009 , Lösel & Wehling 2003 , Luconi et al. 2004 , Jang & Yi 2005 . Moreover, it has been suggested that progesterone binds to the acrosome region, and PGR is localized to the same region in human (Gadkar et al. 2002) and hamster spermatozoa (Noguchi et al. 2008) . Phospholipase C (PLC; Fukami et al. 2003) and/or protein kinase A (Harrison et al. 2000) are involved in progesteroneinduced AR. Progesterone also changes motility parameters (Yang et al. 1994) and enhances hyperactivation in human (Sueldo et al. 1993 ) and hamster spermatozoa (Noguchi et al. 2008) . Although progesterone enhances hyperactivation of human and hamster spermatozoa (Sueldo et al. 1993 , Noguchi et al. 2008 , the effective concentration of progesterone is different between humans and hamsters. For human spermatozoa, the effective concentration of progesterone for the enhancement of hyperactivation was several micrograms per milliliter, the same as the effective concentration for inducing the AR (Osman et al. 1989 , Sueldo et al. 1993 . On the other hand, for hamster spermatozoa, the effective concentration of progesterone for the enhancement of hyperactivation was 20 ng/ml (Noguchi et al. 2008) . Moreover, at a concentration of 20 ng/ml, progesterone increased hamster sperm penetration and did not induce hamster sperm AR (Libersky & Boatman 1995b) . At a concentration of 20 ng/ml, progesterone also enhanced and increased tyrosine phosphorylations associated with hyperactivation of hamster spermatozoa (Noguchi et al. 2008) . The effective progesterone concentration for hamster sperm AR was also several micrograms per milliliter (Libersky & Boatman 1995b) . Libersky & Boatman (1995a) measured progesterone concentration in fluids of reproductive organs, reporting that the progesterone concentration in hamster serum ranged from 5.56 to 12.85 ng/ml, the follicular fluid concentration ranged from 4.2 to 7.4 mg/ml, and the oviductal fluid concentration ranged from 44.04 to 175.06 ng/ml.
It has been suggested that 17b-estradiol (17bE 2 ) is also associated with a regulation of the AR (Luconi et al. 1999 , Baldi et al. 2000 , 2009 . In human spermatozoa, 17bE 2 stimulates calcium influx and suppresses progesterone-induced AR (Luconi et al. 1999 , Baldi et al. 2000 . Estrogen receptors (ESRs) are also present in the cell membrane (Luconi et al. 1999 , Baldi et al. 2000 , 2009 . Moreover, the suppression of progesterone-induced AR by 17bE 2 is non-genomic (Luconi et al. 2004 , Baldi et al. 2009 .
Although the AR is regulated by estrogen (E 2 ) and progesterone via non-genomic regulation, it is not known whether progesterone-enhanced hyperactivation is suppressed by 17bE 2 . In the present study, I have shown that progesterone-enhanced hyperactivation and tyrosine phosphorylations are suppressed by 17bE 2 via non-genomic regulation.
Results

Suppression of progesterone-enhanced hyperactivation by 17bE 2
An earlier study suggested that hamster sperm hyperactivation was enhanced by 20 ng/ml progesterone via non-genomic regulation (Noguchi et al. 2008) . It has been suggested that the AR is induced by progesterone and suppressed by 17bE 2 (Luconi et al. 1999 , Baldi et al. 2000 , 2009 , so I examined whether hyperactivation was also enhanced by progesterone and suppressed by 17bE 2 using hamster spermatozoa.
Although 17bE 2 itself did not affect the percentage of motile spermatozoa and hyperactivation in hamster spermatozoa at all (Fig. 1) , it affected progesteroneenhanced hyperactivation in a concentration-dependent manner (Figs 2 and 3 ). As shown in Fig. 2A and B, 17bE 2 suppressed progesterone-enhanced hyperactivation in a concentration-dependent manner, although it did not affect the percentage of motile spermatozoa when spermatozoa were exposed to 20 ng/ml progesterone after exposure to 20 ng/ml down to 2 fg/ml 17bE 2 . When incubated for 1 (Fig. 2C ), 1.5 (Fig. 2D) , and 2 h (Fig. 2E) , progesterone-enhanced hyperactivation was significantly suppressed by 20 ng/ml, 2 ng/ml, and 200 pg/ml 17bE 2 respectively. On the other hand, no suppression of progesterone-enhanced hyperactivation was observed at a concentration from 2 pg/ml down (20 ng/ml E), mTALPC20 ng/ml 17bE 2 C0.1% (v/v) EtOH; (2 ng/ml E), mTALPC2 ng/ml 17bE 2 C0.1% (v/v) EtOH; (200 pg/ml E), mTALPC 200 pg/ml 17bE 2 C0.1% (v/v) EtOH; (20 pg/ml E), mTALPC20 pg/ml 17bE 2 C0.1% (v/v) EtOH; (2 pg/ml E), mTALPC2 pg/ml 17bE 2 C0.1% (v/v) EtOH; (200 fg/ml E), mTALPC200 fg/ml 17bE 2 C0.1% (v/v) EtOH; (20 fg/ml E), mTALPC20 fg/ml 17bE 2 C0.1% (v/v) EtOH; (2 fg/ml E), mTALPC2 fg/ml 17bE 2 C0.1% (v/v) EtOH.
to 2 fg/ml 17bE 2 . Interestingly, the suppression of progesterone-enhanced hyperactivation by 20 pg/ml 17bE 2 was midway between progesterone-enhanced hyperactivation and vehicle alone, with no significant difference to either. When spermatozoa were exposed to 20 ng/ml to 2 fg/ml 17bE 2 and 20 ng/ml progesterone at the same time, 17bE 2 suppressed progesterone-enhanced hyperactivation in a concentration-dependent manner, although it did not affect the percentage of motile spermatozoa ( Fig. 3A and B) . When incubated for 1 (Fig. 3C ), 1.5 (Fig. 3D) , and 2 h (Fig. 3E ), 20 and 2 ng/ml 17bE 2 significantly suppressed progesterone-enhanced hyperactivation. In contrast, 2 pg/ml to 1 fg/ml 17bE 2 did not suppress progesterone-enhanced hyperactivation. When incubated for 1 h (Fig. 3C) , the suppression of progesterone-enhanced hyperactivation by 200 and 20 pg/ml 17bE 2 was midway between progesteroneenhanced hyperactivation and vehicle alone, with no significant difference to either. When incubated for 1.5 h (Fig. 3D) , the suppression of progesterone-enhanced hyperactivation by 200 pg/ml 17bE 2 was midway between progesterone-enhanced hyperactivation and vehicle alone, with a significant difference to both. However, 20 pg/ml 17bE 2 did not suppress progesteroneenhanced hyperactivation. When incubated for 2 h (Fig. 3E) , 200 pg/ml 17bE 2 significantly suppressed progesterone-enhanced hyperactivation, but 20 pg/ml 17bE 2 had no effect. When spermatozoa were exposed to 20 ng/ml to 2 fg/ml 17bE 2 after exposure to 20 ng/ml progesterone, 17bE 2 did not affect the percentage of motile spermatozoa or progesterone-enhanced hyperactivation at all (Fig. 4) .
The two isomers of E 2 are 17a-estradiol (17aE 2 ) and 17bE 2 , of which 17bE 2 alone has biological activity. When spermatozoa were exposed to 20 ng/ml progesterone after exposure to 20 ng/ml to 200 pg/ml 17aE 2 , 17aE 2 had no effect on the percentage of motile spermatozoa or progesterone-enhanced hyperactivation Figure 2 Effects of 17bE 2 on the percentage of motile spermatozoa and progesterone-enhanced hyperactivation when spermatozoa were exposed to 20 ng/ml progesterone after exposure to 17bE 2 for 5 min. The percentage of motile spermatozoa is shown as an overview of effects (A) when 17bE 2 and progesterone were added to mTALP medium. The percentage of hyperactivation is shown as an overview of effects (B) and after incubation for 1 (C), 1.5 (D), and 2 (E) h after progesterone was added to the mTALP medium. Data are expressed as meanGS.D. (Vehicle), mTALPC0.2% (v/v) EtOH; (20 ng/ml progesterone), mTALPC20 ng/ml progesteroneC0.2% (v/v) EtOH; (20 ng/ml E), mTALPC20 ng/ml 17bE 2 C20 ng/ml progesteroneC0.2% (v/v) EtOH; (2 ng/ml E), mTALPC2 ng/ml 17bE 2 C20 ng/ml progesteroneC0.2% (v/v) EtOH; (200 pg/ml E), mTALPC200 pg/ml 17bE 2 C20 ng/ml progesteroneC0.2% (v/v) EtOH; (20 pg/ml E), mTALPC20 pg/ml 17bE 2 C20 ng/ml progesteroneC0.2% (v/v) EtOH; (2 pg/ml E), mTALPC2 pg/ml 17bE 2 C20 ng/ml progesteroneC0.2% (v/v) EtOH; (200 fg/ml E), mTALPC200 fg/ml 17bE 2 C20 ng/ml progesteroneC0.2% (v/v) EtOH; (20 fg/ml E), mTALPC20 fg/ml 17bE 2 C20 ng/ml progesteroneC0.2% (v/v) EtOH; (2 fg/ml E), mTALPC2 fg/ml 17bE 2 C20 ng/ml progesteroneC0.2% (v/v) EtOH. ( Fig. 5 ), whereas 20 ng/ml to 200 pg/ml 17bE 2 suppressed progesterone-enhanced hyperactivation (Fig. 2B ). In general, 17bE 2 affects cell functions via ESRs. Tamoxifen is an inhibitor of ESRs and was added to the modified Tyrode's albumin lactate pyruvate (mTALP) medium before 17bE 2 and/or progesterone were added to mTALP medium. When spermatozoa were exposed to 1 mmol/l tamoxifen before exposure to 20 ng/ml progesterone, tamoxifen had no effect on the percentage of motile spermatozoa, hyperactivation, or progesteroneenhanced hyperactivation ( Fig. 6A and B ). As shown in Figs 2 and 6D, 17bE 2 suppressed progesterone-enhanced hyperactivation when spermatozoa were exposed to 20 ng/ml 17bE 2 before exposure to 20 ng/ml progesterone. However, the suppression of progesteroneenhanced hyperactivation by 17bE 2 was significantly inhibited by tamoxifen when spermatozoa were exposed to 1 mmol/l tamoxifen before exposure to 20 ng/ml 17bE 2 and 20 ng/ml progesterone (Fig. 6D ). Under the same condition ( Fig. 6C) , tamoxifen had no effect on the percentage of motile spermatozoa.
Suppression of progesterone-enhanced hyperactivation by 17bE 2 via non-genomic regulation
Sperm hyperactivation is enhanced by progesterone via non-genomic regulation associated with PGR (Noguchi et al. 2008) . In the next step, I used FITC/BSA-17bE 2 to determine whether hamster sperm hyperactivation was regulated by 17bE 2 via non-genomic regulation. Generally, 17bE 2 enters the cell, binds to the intracellular ESRs, and induces gene expression (Baldi et al. 1998 , 2009 , Lö sel & Wehling 2003 , Luconi et al. 2004 . However, FITC/BSA-17bE 2 cannot enter the cell because BSA blocks the entry of 17bE 2 into the cell. It follows that the effects of FITC/BSA-17bE 2 occur through non-genomic signals.
As shown in Fig. 7A and B, 7.4 nmol/l, 740 pmol/l, and 74 pmol/l FITC/BSA-17bE 2 , which are converted into w20 ng/ml, 2 ng/ml, and 200 pg/ml 17bE 2 respectively did not affect the percentage of motile spermatozoa and hyperactivation, as with 17bE 2 (Fig. 1) . When spermatozoa were exposed to 20 ng/ml progesterone after exposure to 7.4 nmol/l, 740 pmol/l, and 74pmol/l Figure 3 Effects of 17bE 2 on the percentage of motile spermatozoa and progesterone-enhanced hyperactivation when spermatozoa were exposed to 17bE 2 and 20 ng/ml progesterone at the same time. The percentage of motile spermatozoa is shown as an overview of effects (A) when 17bE 2 and progesterone were added to mTALP medium. The percentage of hyperactivation is shown as an overview of effects (B) and after incubation for 1 (C), 1.5 (D), and 2 (E) h after progesterone was added to the mTALP medium. Data are expressed as meanGS.D. (Vehicle), mTALPC0.2% (v/v) EtOH; (20 ng/ml progesterone), mTALPC20 ng/ml progesteroneC0.2% (v/v) EtOH; (20 ng/ml E), mTALPC20 ng/ml 17bE 2 C20 ng/ml progesteroneC0.2% (v/v) EtOH; (2 ng/ml E), mTALPC2 ng/ml 17bE 2 C20 ng/ml progesteroneC0.2% (v/v) EtOH; (200 pg/ml E), mTALPC200 pg/ml 17bE 2 C20 ng/ml progesteroneC0.2% (v/v) EtOH; (20 pg/ml E), mTALPC20 pg/ml 17bE 2 C20 ng/ml progesteroneC0.2% (v/v) EtOH; (2 pg/ml E), mTALPC2 pg/ml 17bE 2 C20 ng/ml progesteroneC0.2% (v/v) EtOH; (200 fg/ml E), mTALPC200 fg/ml 17bE 2 C20 ng/ml progesteroneC0.2% (v/v) EtOH; (20 fg/ml E), mTALPC20 fg/ml 17bE 2 C20 ng/ml progesteroneC0.2% (v/v) EtOH; (2 fg/ml E), mTALPC2 fg/ml 17bE 2 C20 ng/ml progesteroneC0.2% (v/v) EtOH. a Significant difference compared with vehicle (P!0.05); b
Significant difference compared with 20 ng/ml progesterone (P!0.05); c Significant difference compared with 20 ng/ml E (P!0.05); d Significant difference compared with 2 ng/ml E (P!0.05).
e Significant difference compared with 200 pg/ml E (P!0.05).
FITC/BSA-17bE 2 , progesterone-enhanced hyperactivation was significantly suppressed by 7.4 nmol/l, 740 pmol/l, and 74 pmol/l FITC/BSA-17bE 2 , although they did not affect the percentage of motile spermatozoa ( Fig. 7C and D). The suppression of progesterone-enhanced hyperactivation by 7.4 nmol/l FITC/BSA-17bE 2 was significantly inhibited by 1 mmol/l tamoxifen, although tamoxifen did not affect the percentage of motile spermatozoa ( Fig. 7E and F) .
Binding of 17bE 2 to hamster spermatozoa
Progesterone binds to the acrosome region of the sperm head (Gadkar et al. 2002 , Noguchi et al. 2008 Fig. 8Ac and Ad), although fluorescence of the middle piece of the sperm flagellum appears to be autofluorescence (Noguchi et al. 2008; Fig. 8Aa and Ab) . As shown in Fig. 8Ae -h, it was observed that 7.4 nmol/l FITC/BSA-17bE 2 bound to the acrosome region of the sperm head. Interestingly, 1 mmol/l tamoxifen did not inhibit the binding of FITC/BSA-17bE 2 to the sperm head ( Fig. 8B) , although it did inhibit the effects of 17bE 2 and FITC/BSA-17bE 2 on progesterone-enhanced hyperactivation (Figs 6 and 7). When spermatozoa were exposed to 20 ng/ml 17bE 2 before exposure to 20 ng/ml progesterone, progesteroneenhanced hyperactivation was suppressed by 17bE 2 (Fig. 2) . However, binding of 7 nmol/l FITC/BSA-P, converted w20 ng/ml progesterone, to the hamster sperm head was not inhibited by 20 ng/ml 17bE 2 when spermatozoa were exposed to 20 ng/ml 17bE 2 before exposure to 7 nmol/l FITC/BSA-P (Fig. 8Ca-d) . On the other hand, progesterone-enhanced hyperactivation was not suppressed by 17bE 2 when spermatozoa were exposed to 20 ng/ml 17bE 2 after exposure to 20 ng/ml progesterone (Fig. 4) . Binding of 7.4 nmol/l FITC/BSA17bE 2 to the sperm head was not suppressed by 20 ng/ml progesterone when spermatozoa were exposed to 7.4 nmol/l FITC/BSA-17bE 2 after exposure to 20 ng/ml progesterone ( Fig. 8Ce-h ). Vehicle 20 ng/ml P 20 ng/ml E 2 ng/ml E 200 pg/ml E 20 pg/ml E 2 pg/ml E 200 fg/ml E 20 fg/ml E 2 fg/ml E Vehicle 20 ng/ml P 20 ng/ml E 2 ng/ml E 200 pg/ml E 20 pg/ml E 2 pg/ml E 200 fg/ml E 20 fg/ml E 2 fg/ml E EtOH; (20 ng/ml progesterone), mTALPC20 ng/ml progesterone C0.2% (v/v) EtOH; (20 ng/ml E), mTALPC20 ng/ml 17bE 2 C20 ng/ml progesteroneC0.2% (v/v) EtOH; (2 ng/ml E), mTALPC2 ng/ml 17bE 2 C20 ng/ml progesteroneC0.2% (v/v) EtOH; (200 pg/ml E), mTALPC200 pg/ml 17bE 2 C20 ng/ml progesteroneC0.2% (v/v) EtOH; (20 pg/ml E), mTALPC20 pg/ml 17bE 2 C20 ng/ml progesteroneC0.2% (v/v) EtOH; (2 pg/ml E), mTALPC2 pg/ml 17bE 2 C20 ng/ml progesteroneC0.2% (v/v) EtOH; (200 fg/ml E), mTALP C200 fg/ml 17bE 2 C20 ng/ml progesteroneC0.2% (v/v) EtOH; (20 fg/ml E), mTALPC20 fg/ml 17bE 2 C20 ng/ml progesteroneC0.2% (v/v) EtOH; (2 fg/ml E), mTALPC2 fg/ml 17bE 2 C20 ng/ml progesteroneC0.2% (v/v) EtOH. All spermatozoa exposed to progesterone showed significant enhancement of hyperactivation compared with vehicle (P!0.05). progesterone-enhanced hyperactivation was unaffected by 17bE 2 . Vehicle 20 ng/ml P 20 ng/ml E 2 ng/ml E 200 pg/ml E Vehicle 20 ng/ml P 20 ng/ml E 2 ng/ml E 200 pg/ml E Figure 5 Effects of 17aE 2 on the percentage of motile spermatozoa and progesterone-enhanced hyperactivation. After exposure to 17aE 2 for 5 min, spermatozoa were exposed to 20 ng/ml progesterone. The percentage of motile spermatozoa (A) and hyperactivation (B) are shown when 17aE 2 and progesterone were added to mTALP medium. Data are expressed as meanGS.D. (Vehicle), mTALPC0.2% (v/v) EtOH; (20 ng/ml progesterone), mTALPC20 ng/ml progesterone C0.2% (v/v) EtOH; (20 ng/ml E), mTALPC20 ng/ml 17aE 2 C20 ng/ml progesteroneC0.2% (v/v) EtOH; (2 ng/ml E), mTALPC2 ng/ml 17aE 2 C20 ng/ml progesteroneC0.2% (v/v) EtOH; (200 pg/ml E), mTALPC200 pg/ml 17aE 2 C20 ng/ml progesteroneC0.2% (v/v) EtOH. All spermatozoa exposed to progesterone showed significant enhancement of hyperactivation compared with vehicle (P!0.05). progesterone-enhanced hyperactivation was unaffected by 17aE 2 . 
Effects of 17bE 2 on tyrosine phosphorylations
It is accepted that tyrosine phosphorylations are an important event in sperm hyperactivation (Yanagimachi 1994 , Visconti et al. 1995 , Fujinoki et al. 2006 , Fujinoki 2009 . A previous study (Noguchi et al. 2008) suggested that tyrosine phosphorylations in hamster spermatozoa were enhanced by 20 ng/ml progesterone. As shown in Fig. 9B , several tyrosine phosphorylations occurred during hyperactivation in a time-dependent manner. Four tyrosine phosphorylations, designated as 80u, 85u, 80ut, and 85ut (Fujinoki et al. 2006) , were enhanced by 20 ng/ml progesterone (Noguchi et al. 2008 ; Fig. 9D ). Phosphorylations of 80u and 85u were detected in the urea extract (Fujinoki et al. 2006 ; Fig. 9B  lanes a-f) . Phosphorylations of 80ut and 85ut were detected in the urea-thiourea extract (Fujinoki et al. 2006 ; Fig. 9B lanes g-l) .
When hamster spermatozoa were exposed to 20 ng/ml 17bE 2 , tyrosine phosphorylations including 80u and 85u were not detected in the urea extract ( Fig. 9C lanes a-f) , although 20 ng/ml 17bE 2 itself did not affect the percentage of motile spermatozoa and hyperactivation (Fig. 1) . On the other hand, tyrosine phosphorylations were detected in the urea-thiourea extract when spermatozoa were exposed to 20 ng/ml 17bE 2 (Fig. 9C lanes g-l) . When spermatozoa were exposed to 20 ng/ml progesterone, tyrosine phosphorylations of 80u, 85u, 80ut and 85ut were enhanced when compared with vehicle ( Fig. 9B and D) . As shown in Fig. 9E lanes a-f, tyrosine phosphorylations were not detected in the urea extract when spermatozoa were exposed to 20 ng/ml 17bE 2 before they were exposed to 20 ng/ml progesterone. The tyrosine phosphorylations detected in the urea-thiourea extract, as shown in Fig. 9E lanes g-l, were the same as the tyrosine phosphorylations as shown in Fig. 9C lanes g-l. Under the same conditions, progesterone-enhanced hyperactivation was suppressed (Fig. 2) . As shown in Fig. 6 , 1 mmol/l tamoxifen canceled the effect of 20 ng/ml 17bE 2 on progesterone-enhanced hyperactivation. For tyrosine phosphorylations, 1 mmol/l tamoxifen inhibited the effect of 20 ng/ml 17bE 2 (Fig. 9F ).
Discussion
The AR is induced in a ligand-dependent manner. Progesterone is a major ligand of the AR (Osman et al. 1989 , Baldi et al. 1998 , 2009 , Lö sel & Wehling 2003 , Luconi et al. 2004 ). On the other hand, progesterone also enhances sperm hyperactivation (Sueldo et al. 1993 , Noguchi et al. 2008 . Recently, melatonin was also shown to be a ligand that enhances sperm hyperactivation in hamster (Fujinoki 2008) . It would therefore appear that hyperactivation is enhanced by ligands (Fujinoki 2009 ).
Progesterone-induced AR is suppressed by 17bE 2 through non-genomic regulation in human spermatozoa (Luconi et al. 1999 , Baldi et al. 2000 , 2009 . In the present study, I showed that 17bE 2 suppresses progesterone-enhanced hyperactivation through non-genomic regulation in hamster spermatozoa (see Figs 2, 3, 6 and 7). Since 17bE 2 binds to the acrosome region of the sperm head (see Fig. 8 ), it appears that signals of 17bE 2 start at the sperm head and are transmitted to the sperm flagellum. Calcium is a key molecule in the regulation of AR and hyperactivation by steroid hormones (Luconi et al. 1999 , Baldi et al. 2000 , 2009 , Noguchi et al. 2008 , Fujinoki 2009 ). After progesterone binds to the sperm head, it stimulates calcium influx and activation of PLC (Fukami et al. 2003 , Lö sel & Wehling 2003 , Harper et al. 2004 , Luconi et al. 2004 , Noguchi et al. 2008 , Baldi et al. 2009 , Fujinoki 2009 ). Moreover, spermatozoa are not hyperactivated in the mTALP medium without calcium (Fujinoki 2008 , Noguchi et al. 2008 . In human spermatozoa, 17bE 2 also stimulates calcium influx and suppresses progesteroneinduced AR (Luconi et al. 1999 , Baldi et al. 2000 , 2009 . Although the 17bE 2 signal is unknown, it is likely that the 17bE 2 signal differs from progesterone signals and suppresses progesterone signals via calcium influx (Luconi et al. 1999 , Baldi et al. 2000 , 2009 . In the present study, I did not examine calcium influx induced by 17bE 2 in hamster spermatozoa. Based on the assumption that 17bE 2 stimulates calcium influx, in a future study, I will investigate the relationship between 17bE 2 and calcium influx using hamster spermatozoa. When spermatozoa are hyperactivated, a major intracellular signaling event that occurs is tyrosine phosphorylation (Yanagimachi 1994 , Ho & Suarez 2001 , Ho et al. 2002 , Fujinoki et al. 2006 , Fujinoki 2009 ). As part of progesterone-enhanced hyperactivation, progesterone enhances tyrosine phosphorylations of 80 and 85 kDa proteins such as 80u, 85u, 80ut, and 85ut (Noguchi et al. 2008; see Figs 2 and 9) . Interestingly, 17bE 2 partially suppressed tyrosine phosphorylations (see Fig. 9C ), and 17bE 2 suppressed progesterone-enhanced tyrosine phosphorylations (see Fig. 9E ). Tamoxifen inhibited the suppression of progesterone-enhanced tyrosine phosphorylations by 17bE 2 (see Fig. 9F ), although it did not inhibit the binding of 17bE 2 at the sperm head (see Fig. 8B ). Tyrosine phosphorylation of proteins detected in the urea extract was suppressed by 17bE 2 (see Fig. 9C ). The urea extract contained proteins from many sperm structures, except the fibrous sheath and head (Fujinoki et al. 2006) . On the other hand, tyrosine phosphorylation of proteins detected in the urea-thiourea extract was unaffected (see Fig. 9C ). The urea-thiourea extract contained proteins of fibrous sheath (Fujinoki et al. 2006) . One of the tyrosine phosphorylations associated with hyperactivation is that of AKAP, 80 and/ or 85 kDa components of the fibrous sheath (Carrera et al. 1996 , Jha & Shivaji 2002 . Therefore, tyrosine phosphorylations of 80 and/or 85 kDa proteins detected in the urea-thiourea extract (80ut and 85ut) corresponded to AKAP and were not affected by 17bE 2 , although they were affected by progesterone (Noguchi et al. 2008; see Fig. 9C and D) . Because hamster spermatozoa were hyperactivated in the presence of 17bE 2 , it is likely that tyrosine phosphorylations of 80ut and 85ut are associated with the essential regulatory mechanisms of hyperactivation. Because tyrosine phosphorylation of AKAP is regulated by calcium signals associated with calcium/calmodulin-dependent protein kinase (Carrera et al. 1996) , it seems that tyrosine phosphorylations of 80ut and 85ut are regulated by calcium signals associated with calcium/calmodulindependent kinase. At least, tyrosine phosphorylations of 80ut and 85ut were enhanced by progesterone through calcium signals associated with PLC (Noguchi et al. 2008) . On the other hand, tyrosine phosphorylations of 80 and 85 kDa proteins detected in the urea extract (80u and 85u) were suppressed by 17bE 2 and enhanced by progesterone (Noguchi et al. 2008; see Fig. 9C and D) . Even if 80u, 85u, and other proteins detected in the urea extract were not phosphorylated at tyrosine residues by 17bE 2 , spermatozoa were hyperactivated (see Figs 2 and 9C). These results suggest that tyrosine phosphorylations detected in the urea extract are not associated with the essential regulatory mechanisms of hyperactivation. Because tyrosine phosphorylations detected in the urea extract responded to the effects of steroid hormones, however, it is likely that they are associated with modulatory mechanisms of hyperactivation. Although tyrosine phosphorylations of 80u and 85u are enhanced by progesterone (Noguchi et al. 2008 ; see Fig. 9D ), their regulatory mechanisms are not known at all and have not been identified yet. In a future study, I will investigate the regulatory mechanism of tyrosine phosphorylation of 80u and 85u and their identification. In the present study, I demonstrated that enhancement of sperm hyperactivation was competitively regulated by steroid hormones (see Figs 2 and 3) . It is suggested that the AR is also competitively regulated by steroid hormones (Luconi et al. 1999 , Baldi et al. 2000 , 2009 . For both the AR and the hyperactivation, progesterone enhances the functions and 17bE 2 suppresses the effects of progesterone (Luconi et al. 1999 , Baldi et al. 2000 , 2009 , Noguchi et al. 2008 , Fujinoki 2009 see Figs 2 and 3) . The hyperactivation threshold concentration of 17bE 2 was 20 pg/ml when spermatozoa were exposed to 17bE 2 before exposure to 20 ng/ml progesterone (see Fig. 2 ). When spermatozoa were exposed to both steroid hormones at the same time, the threshold concentration of 17bE 2 was 200 pg/ml (see Hamster spermatozoa were exposed to 20 ng/ml progesterone after exposure to 20 ng/ml 17bE 2 for 5 min. (F) Western blotting against proteins obtained from spermatozoa that were incubated in mTALP medium with 20 ng/ml 17bE 2 , 20 ng/ml progesterone, 1 mmol/l tamoxifen, 0.2% (v/v) EtOH, and 0.1% (v/v) DMSO. Hamster spermatozoa were exposed to 20 ng/ml 17bE 2 after exposure to 1 mmol/l tamoxifen for 5 min. After incubation for 5 min, they were exposed to 20 ng/ml progesterone. Lanes a-f and g-l illustrate results obtained from the urea extract and the urea-thiourea extract respectively. Lanes a and g were incubated for 0 h, lanes b and h were incubated for 0.5 h, lanes c and i were incubated for 1 h, lanes d and j were incubated for 2 h, lanes e and k were incubated for 3 h, and lanes f and l were incubated for 4 h. SDS-PAGE was performed on 5 ml samples per lane. Arrows show tyrosine phosphorylation of 80 and 85 kDa proteins. Numbers on the left side of (A) indicate the molecular weight standard.
Regulation of hyperactivation by steroids cycle, causing concentrations of 17bE 2 and progesterone in the blood and tissues to fluctuate. The balance between the concentrations of 17bE 2 and progesterone accordingly appears to regulate sperm AR and hyperactivation. When 17bE 2 is more dominant over progesterone, enhancement of AR and hyperactivation is suppressed. Conversely, AR and hyperactivation are enhanced when progesterone is dominant over 17bE 2 . In a future study, I will examine the changes in sperm function under different patterns of 17bE 2 and progesterone concentrations.
Materials and Methods
Chemicals
Anti-phosphotyrosine MAB (clone, PT-66), 17aE 2 , 17bE 2 , progesterone, FITC-conjugated and BSA-conjugated 17bE 2 (FITC/BSA-17bE 2 ), FITC-conjugated and BSA-conjugated progesterone (FITC/BSA-P), and tamoxifen were purchased from Sigma Chemical Company. BSA fraction V and Nonidet P-40 (NP-40) were purchased from Merck KGaA. ECL Plus kits and films for ECL were purchased from Amersham Biosciences. Other reagent grade chemicals were purchased from Wako Pure Chemical Industries (Osaka, Japan).
Animals and preparation of hyperactivated spermatozoa
Spermatozoa were obtained from the caudal epididymis of sexually mature (12-20 weeks old) male golden hamsters (Mesocricetus auratus). Hamsters were housed in accordance with the guidelines of the Dokkyo Medical University and the Laboratory Animal Research Center in Dokkyo Medical University of the care and use of laboratory animals. Hyperactivated spermatozoa were prepared according to the method described previously (Fujinoki et al. 2006) , using modified TALP (mTALP) medium containing 101.02 mmol/l NaCl, 2.68 mmol/l KCl, 2 mmol/l CaCl 2 , 1.5 mmol/l MgCl 2 . 6H 2 O, 0.36 mmol/l NaH 2 PO 4 . 2H 2 O, 35.70 mmol/l NaHCO 3 , 4.5 mmol/l D-glucose, 0.09 mmol/l sodium pyruvate, 9 mmol/l sodium lactate, 0.5 mmol/l hypotaurine, 0.05 mmol/l (K)epinephrine, 0.2 mmol/l sodium taurochoric acid, 5.26 mmol/l sodium metabisulfite, 0.05% (w/v) streptomycin sulfate, 0.05% (w/v) potassium penicillin G, and 15 mg/ml BSA (pH 7.4 at 37 8C under 5% (v/v) CO 2 in air). An aliquot of caudal epididymal spermatozoa was placed in the bottom of a test tube, and several milliliters of the mTALP medium were carefully added, followed by incubation for 5 min to allow spermatozoa to swim up. The supernatant containing motile spermatozoa was collected, placed on a culture plate (35 mm dish), and incubated for 4 h at 37 8C under 5% (v/v) CO 2 in air to achieve hyperactivation. Steroid hormones and tamoxifen were dissolved in ethanol (EtOH) and dimethyl sulfoxide (DMSO) respectively, and then added to the mTALP medium after placing the motile spermatozoa on the culture plate.
Measurement of the percentage of motile spermatozoa and hyperactivation
The percentage of motile spermatozoa and hyperactivation measurements were performed according to the method described in previous studies (Fujinoki et al. 2001b (Fujinoki et al. , 2006 . Hamster spermatozoa suspended in the mTALP medium were diluted 10-fold and placed on the culture plate (35 mm dish). Motile and hyperactivated spermatozoa were recorded on a DVD using a CCD camera (Progressive 3CCD, Sony Corp., Tokyo, Japan) attached to a microscope (IX70, Olympus Corp., Tokyo, Japan) with phase-contrast illumination and a small CO 2 incubator (MI-IBC, Olympus). Each observation was performed at 37 8C and recorded for 2 min, and the analyses comprised counting the numbers of total spermatozoa, motile spermatozoa, and hyperactivated spermatozoa in 20 different fields. The percentage of motile spermatozoa and hyperactivation were respectively defined as (the number of motile spermatozoa/the number of total spermatozoa)!100 and (the number of hyperactivated spermatozoa/numbers of total spermatozoa)!100. Statistical analyses were performed using the post hoc test of ANOVA.
Ligand assays of 17bE 2 and progesterone
Ligand assays of 17bE 2 and progesterone were performed according to the method described previously (Noguchi et al. 2008 ). An aliquot of caudal epididymal spermatozoa was placed on the bottom of a test tube, and several milliliters of mTALP medium with FITC/BSA-17bE 2 or FITC/BSA-P were carefully added, followed by incubation for 5 min to allow spermatozoa to swim up. The supernatant containing motile spermatozoa was collected, placed on a culture dish, and incubated for 5 min at 37 8C under 5% (v/v) CO 2 in air. After incubation, several microliters of the supernatant were placed on a glass slide without fluorescence and observed using a light microscope (IX70, Olympus) with phase-contrast illumination and a fluorescence unit.
Preparation of sperm protein extracts
Sperm proteins were extracted according to the method described previously (Fujinoki et al. 2006) . In brief, spermatozoa were suspended at 30 mg spermatozoa/ml in the urea solution containing 7 mol/l urea and 10% (v/v) 2-mercaptoethanol. After pipetting, the suspension was incubated on ice for 10 min. Following centrifugation at 15 000 g for 10 min at 4 8C, the supernatant was used as the urea extract. The precipitate was resuspended in the same volume of urea-thiourea solution containing 5 mol/l urea, 1 mol/l thiourea, 10% (v/v) 2-mercaptoethanol, and 2% (v/v) NP-40 as the urea solution. After pipetting, the suspension was incubated on ice for 10 min, centrifuged at 15 000 g for 10 min at 4 8C, and the supernatant was used as the urea-thiourea extract.
SDS-PAGE
SDS-PAGE was performed using the Laemmli protocol (Laemmli 1970 ) using a separating gel of 10% (w/v) polyacrylamide containing 0.1% (w/v) SDS.
Western blotting
Western blotting was performed according to the method described previously (Fujinoki et al. 2001b (Fujinoki et al. , 2006 . The blotted membrane was blocked with 5% (w/v) skim milk in Trisbuffered saline (TBS) containing 0.15 mol/l NaCl and 20 mmol/l Tris-HCl (pH 7.5) for 1 h at 20 8C, and incubated with antiphosphotyrosine MAB (clone, PT-66) (1:1000 dilution with 5% (w/v) skim milk in TBS) for 1 h at 20 8C. Following a TBS wash, the membrane was incubated with anti-mouse IgG antibodyconjugated peroxidase (1:5000 dilution with 5% (w/v) skim milk in TBS). Color reactions were conducted using the ECL Plus kit.
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